Companeros International

Companeros International, doing business as The Copera Co Inc., operates as a non-profit organization serving as a federal grant sub-recipient focused on HIV, hepatitis C, and opioid use intervention research and community health services along the Texas-Mexico border. The vendor holds no prime federal contracts or grants; all four recent awards are sub-awards under grants issued by the National Institutes of Health (NIH), with a combined obligated value of $1.1 million across four sub-awards.

Companeros's customer base is concentrated within the National Institutes of Health. The National Institute on Drug Abuse (NIDA) has issued three sub-awards totaling approximately $614,547 and beyond, while the National Institute of Mental Health has issued one sub-award. All four sub-awards execute through The Regents of the University of California, San Francisco as the prime grant recipient.

The vendor's recent work centers on intervention development and feasibility studies in substance use and infectious disease. Under a February 2026 sub-award from a UCSF-led NIH K01 grant titled "Proyecto VIDA: Applying optimized interventions and phylogenetics to address HIV, hepatitis C, and opioid use among people who inject drugs along the Texas-Mexico Border," Companeros conducts study recruitment, screening, enrollment, and consent processes; contributes to protocol refinement; administers feasibility and acceptability trials through in-depth interviews, key informant interviews, and focus group discussions; and performs data management and qualitative transcription. A June 2025 sub-award supports work on bio-behavioral intervention optimization to promote viral suppression among HIV-positive people who inject drugs on the U.S.-Mexico border. A July 2023 sub-award supports participation in the Center for AIDS Prevention Studies. Activity remains sparse—one award per year across the period captured—with no recompete exposure in the near term based on current obligated work. Companeros operates formal partnerships with Centro Ambulatorio para la Prevención y Atención en SIDA e Infecciones de Transmisión Sexual (CAPASITS) for HCV testing and care and Centros de Integración Juvenil (CIJ) for opioid agonist treatment delivery.